SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB ...

SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB ...

Two people were arrested after authorities say they were alerted to a large amount of synthetic cannabinoids delivered to a ...

Synthetic cannabinoids, a class of new psychoactive substances, have emerged as a significant public health and social stability threat due to their structural diversity, rapid iteration, and stronger ...

Adolescent vaping of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids increased significantly from 2021 to 2023.

Medical marijuana programs across Europe vary greatly but most only allow cannabis products to be dispensed through ...

Artelo Biosciences Inc (NASDAQ:ARTL) saw its stock jump 10% after unveiling encouraging preclinical results for its lead drug ...

As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss a gray area when the 2018 Farm Bill legalized ...

Argent BioPharma (ASX: RGT) has commenced the supply of a cannabinoid-based active pharmaceutical ingredient (API) to treat ...

Argent BioPharma initiates supply of EU-GMP Cannabinoid API for epilepsy treatment at Slovenia’s largest hospital. ... Read ...

Differentiated Therapeutic Profile: These findings underscore ART12.11’s potential as a highly differentiated candidate for treating depression and anxiety, especially in patients where cognitive ...